Helixworks

Cork, Ireland Founded: 2016 • Age: 10 yrs
Developer of DNA-based data storage solutions

About Helixworks

Helixworks is a company based in Cork (Ireland) founded in 2016. Helixworks offers products and services including DNA Data Storage, Podcast Series, and Genome Storage Project. Helixworks operates in a competitive market with competitors including Tessera Therapeutics, Phase Genomics, Genomenon, SeqOne and Hexagon Bio, among others.

  • Headquarter Cork, Ireland
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website helix.works
  • Social LinkedIn X Facebook YouTube
  • Legal Name Helixworks Technologies Limited
Key Metrics

Products & Services of Helixworks

Helixworks offers a comprehensive portfolio of products and services, including DNA Data Storage, Podcast Series, and Genome Storage Project.

DNA Data Storage
Data Storage Technology

Encodes digital data into DNA for long-term preservation and archival

Podcast Series
Educational Content

Discusses advancements in DNA storage and molecular systems

Genome Storage Project
Biotech Application

Stores human genome in 5D crystals for eternal backup

Apps and channels of Helixworks

its YouTube channel Helixworks Technologies has 17 subscribers and 11 videos.

Helixworks Technologies
YouTube 17 subscribers 11 videos Science & Technology
Open channel

Videos from Helixworks

The most watched videos on Helixworks's YouTube channel, Helixworks Technologies (17 subscribers). Click a video to play it here.

A new biotechnology from Helixworks' engineers
488 views
Eshna Gogia at RebelBio Future Conference 2017
433 views
Enda Kenny on Helixworks
233 views
Demo of supply chain transparency enabled by DNA verification 🧬
81 views

More on Helixworks Technologies.

Funding Insights of Helixworks

  • Total Rounds 4
  • Last Round Grant β€” $1.82M
  • Investors Count 3

All 4 funding rounds of Helixworks with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2022$1.82MGrant––
Oct 2019$487,052Grant––
Jun 2019–Grant––
Feb 2019–Seed–dlab
–
Valuation history

3 investors in total: 3 institutional.

Investors in Helixworks

Helixworks has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, European Union and dlab.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital and support are provided for web3 startups by dlab.
–dlab.vc-
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Institution of the European Union responsible for upholding the EU treaties
1958ec.europa.euBrussels, Belgium
Premium access

Investor details for Helixworks

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Helixworks

3 dated milestones of Helixworks across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Helixworks is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $1.8M.

Competitors of Helixworks

Helixworks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tessera Therapeutics, Phase Genomics, Genomenon, SeqOne and Hexagon Bio, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tesseratherapeutics.com2017Cambridge, United States$610M149
New genome engineering technology is provided for treating multiple diseases.
phasegenomics.com2015Seattle, United States$5.75M19
Laboratory and computational services for DNA proximity analysis are provided.
genomenon.com2014Ann Arbor, United States$36.84M–
AI-based bioinformatics tools and genomic variants meta-database are developed.
seqone.com2017Montpellier, France$48.79M–
Bioinformatics tools for genome sequencing data analysis are provided.
hexagonbio.com2017Menlo Park, United States$205.6M34
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
preventiongenetics.com2004Marshfield, United States–205
Clinical gene sequencing services and duplication tests are provided.
intusbio.com2014Farmington, United States$4.14M–
Sequencing technology is developed for microbiome testing and pathogen identification.
fdna.com2010Herzliya, Israel––
Neurogenetic solutions for facial dysmorphic feature detection are developed.
cellanome.com2020Palo Alto, United States$42.71M–
Developer of the omic data platform for researchers
gendx.com2005Utrecht, Netherlands––
Develops and markets a line of In Vitro Diagnostic (IVD) tests and services, analysis software and education
Premium access

Detailed competitors of Helixworks

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Helixworks

The website of Helixworks (helix.works) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▼ 40.2% vs previous month

Latest news on Helixworks

Premium access

Complete news archive for Helixworks

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Helixworks

10 companies that operate in the same segment as Helixworks (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Helixworks

Helixworks was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Helixworks is headquartered in Cork, Ireland.

Helixworks was founded in 2016 in Cork, Ireland, within the biotechnology sector. DNA-based technologies are developed to encode digital information into synthetic strands, creating a compact storage medium. This method supports archival needs for diverse data, such as genomic sequences and extensive files. Operations emphasize scalable solutions for long-term data preservation across industries.

Helixworks's top competitors include Tessera Therapeutics, Phase Genomics and PreventionGenetics.

Helixworks offers DNA Data Storage, Podcast Series, and Genome Storage Project.

Helixworks has 3 investors. Key investors include European Commission, European Union, and dlab.

Helixworks operates through Helixworks Technologies Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available